What is PCI Pharma Services?
PCI Pharma Services operates as an integrated, full-service provider catering to companies within the global healthcare industry. Its extensive service portfolio encompasses analytical services, formulation development, clinical trial supply management, commercial manufacturing and packaging, Qualified Person (QP) services, supply chain management, and specialized storage and distribution solutions. Headquartered in Philadelphia, Pennsylvania, the company maintains a significant operational footprint across the United States and Europe, positioning it as a key partner for pharmaceutical and biotechnology firms navigating complex development and commercialization pathways.
How much funding has PCI Pharma Services raised?
PCI Pharma Services has raised a total of $920M across 1 funding round:
Debt
$920M
Debt (2020): $920M with participation from Jefferies
Key Investors in PCI Pharma Services
Jefferies
Jefferies is a global investment banking and capital markets firm that provides a wide range of financial advisory, capital raising, and asset management services. Their involvement suggests a strategic financial backing aimed at supporting PCI Pharma Services' growth and operational expansion within the healthcare sector.
What's next for PCI Pharma Services?
The substantial enterprise-level funding and recent strategic investment signal a period of accelerated growth and expansion for PCI Pharma Services. This capital infusion is expected to bolster the company's capabilities in critical areas such as advanced manufacturing technologies, supply chain resilience, and the expansion of its service offerings to meet evolving market demands. The company is poised to further solidify its market position by enhancing its integrated service model, potentially through strategic acquisitions or organic development, thereby supporting its clients from early-stage development through to commercial launch and lifecycle management.
See full PCI Pharma Services company page
